Product Details
| Product Name:
VMY-1-101 |
CAS No.:
1209002-42-5 |
| Supply Ability:
10g |
Release date:
2025/08/21 |
Product Introduction
Bioactivity
| Name | VMY-1-101 |
| Description | VMY-1-101 is a synthesized fluorescent CDK inhibitor. VMY-1-101 demonstrates potent CDK inhibitory activity, enhanced induction of G2/M arrest and modest apoptosis as compared to purvalanol B. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | VMY-1-101 | HN-11501 | HN11501 |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:1209002-43-6
$2500.00 / 100mg
-
CAS:1434047-61-6
$2500.00 / 100mg
-
CAS:1228660-00-1
$1980.00 / 50mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$0.00/10g |
|
HangZhou RunYan Pharma Technology Co.,LTD.
|
2024-09-22 |
|
|
$147.00/5mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-10-04 |
|
|
$239.00/1mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-10-17 |
United States